Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04846127 · ClinicalTrials.gov registry record
CanGaroo® Registry Study
A clinical trial of Arrhythmias, Cardiac, sponsored by Elutia.
- Completed
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT04846127: Completed study of Arrhythmias, Cardiac, sponsored by Elutia.
NCT04846127 is a study of Arrhythmias, Cardiac that has completed, run by Elutia. The registered enrollment target is 500 participants, roughly in line with the 533-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target. The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04846127, a study of Arrhythmias, Cardiac, has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation
Primary Outcome
Cohort comparison of clinically significant factors such as physical and demographic characteristics, medical history risk factors related to post-procedure events, and associations with outcomes and events.
Conditions Studied
Interventions
- DEVICE CanGaroo Envelope
Study Locations (20)
Florida
- Daytona Heart Group - Daytona Beach
- The Arrhythmia Center of South Florida - Delray Beach
- Florida Heart Rhythm Specialists, PLLC - Fort Lauderdale
- VA Medical Center - Gainesville
- Cardiovascular Associates/Osceola Regional Medical Center - Kissimmee
- Advent Health - Tampa
Michigan
- Sparrow Clinical Research Institute - Lansing
- Ascension Providence Hospital - Southfield
- Metro Health/University of Michigan Health - Wyoming
North Carolina
- UNC Health/NC Heart & Vascular Research - Raleigh
- New Hanover Regional Medical Center - Wilmington
Arkansas
- Arkansas Heart Hospital - Little Rock
Indiana
- Baptist Health Floyd - New Albany
Kentucky
- St. Joseph Hospital - Lexington
Maine
- Eastern Maine Medical Center - Bangor
Massachusetts
- Brigham & Women's Hospital, Cardiovascular Division - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-05-25 |
| Est. Completion | 2024-10-17 |
What the finished NCT04846127 record still lists
NCT04846127 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 533-participant average among 17 other Arrhythmias, Cardiac trials with a reported enrollment target.
The record links to 1 condition, with Arrhythmias, Cardiac appearing as the primary indexed condition, and to 1 intervention - of which CanGaroo Envelope is the first listed.
NCT04846127 names 20 study sites across 12 states, led by Florida, Michigan, North Carolina.
Frequently Asked Questions
What is clinical trial NCT04846127 about?
NCT04846127 is a clinical study titled "CanGaroo® Registry Study". A Multi-Center Registry Evaluating Participants Who Receive CanGaroo Envelope or No Envelope During their CIED Implantation
What is the current status of trial NCT04846127?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2021-05-25. Estimated completion is 2024-10-17.
What conditions does trial NCT04846127 study?
This clinical trial studies the following conditions: Arrhythmias, Cardiac.
What interventions are being tested in trial NCT04846127?
The interventions under investigation include: CanGaroo Envelope (DEVICE).
Who is sponsoring clinical trial NCT04846127?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04846127 being conducted?
This trial has 20 study locations across Arkansas, Florida, Indiana, Kentucky, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arrhythmias, Cardiac
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04846127's enrollment target sits among peer trials
500 4th of 17 higher than 14 of 17 other Arrhythmias, Cardiac trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arrhythmias, Cardiac trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
RECRUITING
-
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
RECRUITING · NA
-
AI Powered Mapping Technology for Identifying Arrhythmias
RECRUITING
-
Machine Learning in Atrial Fibrillation
RECRUITING
-
Cardiac Implantable Electronic Device (CIED) Research Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI